Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma
M. F. Orth, J. S. Gerke, T. Knosel, A. Altendorf-Hofmann, J. Musa, R. Alba Rubio, S. Stein, M. Dallmayer, M. C. Baldauf, A. Marchetto, G. Sannino, S. Ohmura, J. Li, M. Hakozaki, T. Kirchner, , T. G. P. Grunewald
This study identifies AMPD2 as a prognostic biomarker for undifferentiated pleomorphic sarcoma using transcriptome analysis, immunohistochemistry, and functional assays.
bioRxiv · Mar 31, 2018Pathology